The estimated Net Worth of William Muecke is at least $75 dollars as of 29 June 2023. William Muecke owns over 251 units of Clever Leaves stock worth over $22 and over the last 3 years William sold CLVR stock worth over $53.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
William Muecke CLVR stock SEC Form 4 insiders trading
William has made over 1 trades of the Clever Leaves stock since 2023, according to the Form 4 filled with the SEC. Most recently William sold 251 units of CLVR stock worth $53 on 29 June 2023.
The largest trade William's ever made was selling 251 units of Clever Leaves stock on 29 June 2023 worth over $53. On average, William trades about 63 units every 0 days since 2022. As of 29 June 2023 William still owns at least 110,257 units of Clever Leaves stock.
You can see the complete history of William Muecke stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's William Muecke's mailing address?
William's mailing address filed with the SEC is C/O CLEVER LEAVES HOLDINGS INC., 6501 CONGRESS AVE, BOCA RATON, FL, 33487.
Insiders trading at Clever Leaves
Over the last 4 years, insiders at Clever Leaves have traded over $235,856 worth of Clever Leaves stock. The most active insiders traders include Elisabeth H Demarse, Andres Fajardo a Kyle Detwiler. On average, Clever Leaves executives and independent directors trade stock every 29 days with the average trade being worth of $1. The most recent stock trade was executed by Henry R Iii Hague on 8 March 2024, trading 170 units of CLVR stock currently worth $563.
What does Clever Leaves do?
Clever Leaves Holdings Inc. operates as a cannabis company. The company operates through two segments, Cannabinoid and Non-Cannabinoid. The Cannabinoid segment engages in the cultivation, extraction, manufacturing, commercialization, and distribution of cannabinoid products internationally. The Non-Cannabinoid segment is engaged in formulating, manufacturing, marketing, selling, distributing, and commercializing nutraceutical and other natural remedies, wellness products, detoxification products, and nutritional and dietary supplements for mass retailers, specialty and health retailers, and distributors in the United States. The company was founded in 2017 and is based in Boca Raton, Florida.
What does Clever Leaves's logo look like?
Complete history of William Muecke stock trades at Clever Leaves
Clever Leaves executives and stock owners
Clever Leaves executives and other stock owners filed with the SEC include:
-
Andres Fajardo,
Pres & Director -
Henry R. Hague III,
Chief Financial Officer -
Julian Wilches,
Chief Regulatory Officer -
Kyle Detwiler,
CEO & Chairman -
Caroline Kliess,
Managing Director of Germany -
Camilo Bohorquez,
Head of Colombia -
Diana Sigüenza,
Strategic Communications Director -
Del Wright,
Chief Strategy Officer -
Gustavo Escobar,
Head of Commercial, Latin America -
Andrew Miller,
Head of Commercial EMEA, North America, and Asia- Pacific -
Amit Pandey,
Exec. VP of Fin. -
Diana Sigüenza,
Strategic Communications Director -
David M. Kastin Esq.,
Gen. Counsel & Corp. Sec. -
William Muecke,
Director -
George J Schultze,
Director -
Elisabeth H Demarse,
Director -
Etienne H. Deffarges,
Director -
Gary M Julien,
Director -
Amit Pandey,
Interim CFO -
Julian Wilches,
Chief Regulatory Officer -
Henry R Iii Hague,
Chief Financial Officer -
Kyle Detwiler,
Chief Executive Officer -
Andres Fajardo,
Chief Executive Officer -
David Kastin,
General Counsel -
Special Purpose Acquisition...,
10% owner